Post-effective amendment to a registration statement that is not immediately effective upon filing

Stockholders' Equity (Tables)

v3.8.0.1
Stockholders' Equity (Tables)
12 Months Ended
Jun. 30, 2017
Equity [Abstract]  
Schedule of stock-based compensation expense

The Company recorded stock-based compensation expense for the shares issued to consultants that have vested, which is a component of operating expenses in the Consolidated Statement of Operations as follows:

 

            Stock-Based Compensation  
                     
            For the Year Ended  
Month of Original Grant     Shares
Issued
    June 30,
2017
    June 30,
2016
 
December 2015       230,000     $ 945,189     $ 342,811  
March 2016       60,000       261,214       71,786  
August 2016       40,000       147,600        
January 2017       50,000       194,776        
        380,000     $ 1,548,779     $ 414,597  
Schedule of Black-Scholes option pricing model with weighted average assumptions

The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following weighted average assumptions:

 

Expected term (years)     6.25  
Risk-free interest rate     1.29 %
Volatility     47 %
Dividend yield     0 %
Schedule of the option activity

The following is a summary of the option activity:

 

      Options     Weighted
Average
Exercise
Price
 
Outstanding – July 1, 2015       160,000     $ 1.50  
Exercisable – July 1, 2015           $  
Granted              
Exercised              
Forfeited/Cancelled              
Outstanding – June 30, 2016       160,000       1.50  
Exercisable – June 30, 2016       40,000       1.50  
Granted              
Exercised              
Forfeited/Cancelled              
Outstanding – June 30, 2017       160,000     $ 1.50  
Exercisable – June 30, 2017       80,000     $ 1.50
Schedule of resricted shares

The following is a summary of restricted shares:

 

Grant Date   Shares
Issued
    Fair
Value (1)
    Shares
Vested
 
June 2014     307,876     $ 1,294,029       121,530  
July 2014     32,408       48,612       23,791  
August 2014     81,020       326,323       8,102  
September 2014     129,633       352,282       13,667  
March 2015     72,918       401,717        
October 2015     293,000       439,500        
November 2015     36,200       54,300        
December 2015     300,000       1,393,000       230,000  
January 2016     40,000       68,000        
March 2016     60,000       333,000       60,000  
June 2016     118,000       535,809        
August 2016     351,000       1,489,247       40,000  
January 2017     192,000       1,165,122        
February 2017     110,000       697,500        
March 2017     20,000       135,000        
      2,144,055     $ 8,733,441       497,090  

 

(1) – The fair value of the restricted stock awards as shown above is based on either the balance sheet date for consultants or grant date for employees.